GCGR and type 1 diabetes mellitus: Most recently, a monoclonal glucagon receptor antagonist (Ab-4) corrected both glycemia and provoked restoration of β−cells in type 1 diabetic rodents (NOD and PANIC-ATTAC mouse models) as well as in mouse-implanted human islet xenografts42.